Ikarian Capital, LLC Galapagos Nv Call Options Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $7.62 Million - $11.2 Million	100,000 New	100,000 $7.71 Million
Q2 2020 Aug 14, 2020	SELL	$185.52 - $231.25 $6.49 Million - $8.09 Million	-35,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $5.01 Million - $9.59 Million	35,000 New	35,000 $6.86 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.